Choose from a variety of resources to learn how you can propel your healthcare institution forward
From the Economist Intelligence Unit, review educational reports on topics that highlight the importance of the laboratory in delivering the best possible healthcare.
Build key laboratory competencies to better serve physicians and patients with our learning guides.
Abbott has developed a library of digital resources to help you in your work. Use these publications to keep abreast of the latest information in laboratory science, important therapeutic areas, and how Abbott has contributed to the industry.
The prevalence of Hepatitis C in Egypt was unlike any other country in the world. Discover why Egypt now appears to be on the path to successfully eliminating viral Hepatitis and how their approach can offer valuable lessons to other countries.
There is evidence that viral Hepatitis is a growing danger in Uganda. However, a lack of data made it difficult to create a strategic plan for the way forward. Learn about Uganda's multifaceted policy response to address this important issue.
The scale of Hepatitis C in Pakistan required elevation to a public health priority after past inadequate action, while Hepatitis B declined with a successful vaccination program. Explore Pakistan's renewed commitment to fighting both Hepatitis C and B.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
